Evolocumab for PCSK9 Lowering in Early Acute Sepsis (The PLEASe Study)
Clinical trial NCT03869073 · UNKNOWN
Trial details
- NCT number
- NCT03869073
- Sponsor
- University of British Columbia
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-11
- Primary completion
- 2021-02-11
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.